Alzheimer’s drug trials plagued by lack of racial diversity

Sara Reardon

Nature, 2023, vol. 620, issue 7973, 256-257

Abstract: Under-representation of people of colour sparks concerns over the safety and efficacy of drugs in diverse populations.

Keywords: Medical research; Alzheimer's disease (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-023-02464-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:620:y:2023:i:7973:d:10.1038_d41586-023-02464-1

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-023-02464-1

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().